Ultragenyx Pharmaceutical's shares increased by over 3.2% following the agreement to sell a Rare Pediatric Disease Priority Review Voucher for $210 million. The voucher was granted after FDA approval of GENGLYCOS (DTX401) for glycogen storage disease type Ia, allowing Ultragenyx to gain significant non-dilutive capital to support rare disease therapy development and advance profitability. The sale, subject to regulatory conditions, highlights the FDA program's role in funding rare disease drug development and strengthens Ultragenyx's financial position as it progresses its pipeline.
Ultragenyx Pharmaceutical's $210 million voucher sale is notable alongside today's Health sector activity on Pluang. For readers following Health stocks, here is Pluang's market snapshot as of Oct 08, 2026 00:01 WIB: out of 100 priced US Health-sector stocks, 59 rose and 40 fell. Among movers, AdaptHealth Corp (AHCO) rose 3.81% with 100% sell order activity, Eli Lilly And Co (LLY) gained 3.41% with 55% sell orders, and 10X Genomics Inc (TXG) declined 3.84% with a typical hold time of 92 days.
Constellation Brands reported strong Q2 fiscal 2027 earnings of $3.74 per share, beating estimates and showing a 3% year-over-year increase. Net sales rose 6% to $2.63 billion, driven by 5% growth in beer sales and 17% in wine and spirits. Despite th...
SCWorx Corp. has resumed trading on the Nasdaq Capital Market on October 7, 2026, after a suspension that began in April. The company successfully reversed a delisting decision by regaining compliance with Nasdaq's minimum bid price and publicly held...
Star Bulk Carriers' Chief Operating Officer, Reskos, purchased 10,000 shares at $28.27 each. This insider buying signals confidence in the company's prospects and may encourage investors to consider buying SBLK stock. The move could indicate positive...
Several analysts including Morgan Stanley, Scotiabank, and Wells Fargo have lowered their price targets for Vale due to rising all-in costs and volatile iron ore prices. Despite the stock trading below these new targets, indicating potential upside, ...
Charter Communications will announce its financial and operating results for the third quarter ended September 30, 2026, on November 6, 2026. The company will issue a press release at 7:00 a.m. ET followed by a live webcast at 8:30 a.m. ET accessible...
